Abbott Laboratories | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (88)

Latest Posts

About This Stock More About This Stock
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
Article By: The Tokenist
Wednesday, April 17, 2024 9:30 AM EDT
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.
In this article: ABT
Read
3 Buy Rated Stocks To Consider As Earnings Approach
Article By: Zacks Investment Research
Saturday, April 13, 2024 2:20 AM EDT
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.
In this article: ABT, ASML, IBKR
Read
Abbott Laboratories Dividend Stock Analysis
Article By: Dividends4Life
Friday, April 12, 2024 7:00 AM EDT
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the United States.
In this article: ABT
Read
Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks
Article By: Sheraz Mian
Friday, April 5, 2024 11:55 PM EDT
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
In this article: ABT, PANW, TMUS Also: AMP, EPD, PNC
Read
Abbott Laboratories Barely Hits Q4 Target With $1.19 EPS
Article By: The Tokenist
Wednesday, January 24, 2024 8:50 AM EDT
Abbott Laboratories announces Q4 results with $10.24 billion in revenue and an EPS of $1.19.
In this article: ABT
Read

Latest Tweets for $ABT

No tweets yet!

PARTNER HEADLINES